Volume | 896,826 |
|
|||||
News | - | ||||||
Day High | 177.85 | Low High |
|||||
Day Low | 167.07 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Inspire Medical Systems Inc | INSP | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
176.22 | 167.07 | 177.85 | 167.83 | 174.37 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
20,595 | 896,826 | $ 170.48 | $ 152,893,031 | - | 123.27 - 330.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:58:43 | 2 | $ 167.26 | USD |
Inspire Medical Systems (INSP) Options Flow Summary
Inspire Medical Systems Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.97B | 29.59M | - | 624.8M | -21.15M | -0.72 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Inspire Medical Systems News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INSP Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 253.50 | 257.40 | 156.83 | 184.25 | 1,571,393 | -84.50 | -33.33% |
1 Month | 231.95 | 257.40 | 156.83 | 210.40 | 772,776 | -62.95 | -27.14% |
3 Months | 190.99 | 257.40 | 156.83 | 206.22 | 555,716 | -21.99 | -11.51% |
6 Months | 126.88 | 257.40 | 123.27 | 189.51 | 609,919 | 42.12 | 33.20% |
1 Year | 290.38 | 330.00 | 123.27 | 208.52 | 596,989 | -121.38 | -41.80% |
3 Years | 192.82 | 330.00 | 123.27 | 213.62 | 385,308 | -23.82 | -12.35% |
5 Years | 52.12 | 330.00 | 40.53 | 175.54 | 353,479 | 116.88 | 224.25% |
Inspire Medical Systems Description
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States. |